Tyra Biosciences, Inc.TYRANASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank83
3Y CAGR+52.7%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+52.7%/yr
Annual compound
Percentile
P83
Within normal range
vs 3Y Ago
3.6x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$12.81M-27.6%
2024$17.70M+63.7%
2023$10.81M+200.1%
2022$3.60M+60133.3%
2021$-6000.00+84.6%
2020$-39000.00+95.9%
2019$-943000.00-